Suggestions
Emily Gransky
VP, Head of Recruiting
Emily Gransky is the Vice President of Recruiting at RA Ventures (RAVen), which is the early-stage venture arm of the multi-stage investment firm RA Capital.1 In her role, she leads and executes full-cycle recruiting across all new companies and portfolio companies within RAVen, working closely with senior leaders, venture partners, and managing directors.1
Emily has an impressive background in talent acquisition and recruitment in the biotech industry:
Professional Experience
- Current Role: VP of Recruiting at RAVen (RA Ventures)
- Previous Positions:
- Director of Talent Acquisition at Generation Bio
- Director of Talent Acquisition and Operations at Flagship Pioneering
- Associate Director, Head of Global Talent Acquisition at bluebird bio
Achievements
At bluebird bio, Emily played a crucial role in the company's growth, helping it expand from 300 to 1000 employees.1
Education
Emily holds a BS in Chemical Engineering from Rensselaer Polytechnic Institute in New York.1
Expertise
Emily is highly regarded in the field of biotech recruitment. She has extensive experience in:
- Full-cycle recruiting
- Building talent systems to support growth in pre-series B biotech startups
- Leading hiring across various functions in biotech companies
Her expertise is particularly valuable in the competitive environment of early-stage biotech recruiting, where she helps companies stand out and attract top talent.1
Emily Gransky's LinkedIn username is emilygransky, as confirmed by the query.2
Highlights
Come join us at RA Ventures (RAVen), the incubator arm of RA Capital Management! We are seeking a seasoned Program Management Leader to oversee project workflow and track the status of all projects and newcos across our team. This role offers a highly visible opportunity to collaborate with Venture Partners, EIRs, and our broader team. Join us in shaping the future of life science, healthcare and AI! #Innovation #ProgramManagement #RAVentures
Blackbird is looking to disrupt the clinical trial execution process to accelerate the delivery of high quality data and potentially deliver new therapies to patients faster. If you're looking for a role that is outside of traditional study management, please consider checking us out!
